Last reviewed · How we verify

NCT03917901

Computer-Delivered Intervention for Individuals With Obesity and Elevated Anxiety Sensitivity

Completed NA Results posted Last updated 26 August 2024
What this trial tests

NA trial testing Anxiety Sensitivity Training in Obesity in 131 participants. Completed in 6 March 2021.

Timeline
16 September 2019
Primary endpoint
6 March 2021
6 March 2021

Quick facts

Lead sponsorUniversity of Houston
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment131
Start date16 September 2019
Primary completion6 March 2021
Estimated completion6 March 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Houston

Who can join

18 and older, any sex, with Obesity or Anxiety Sensitivity. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Anxiety Sensitivity Index-3 Primary · Baseline,1-week, 2-week and 1-month follow-up

The Anxiety Sensitivity Index-3 is an 18-item measured that will be used to assess sensitivity to, and fear of, the potential negative consequences of anxiety-related symptoms and sensations. Items are rated on a 5-point Likert scale, ranging from 0 (Very Little) to 4 (Very Much). Scores will be calculated by summing all items (possible range = 0 -72), with lower scores indicating a better outcome.

Baseline
GroupValue95% CI
Anxiety Sensitivity Training43.44± 12.27
Health Control43.00± 12.43
1-Week Follow-up
GroupValue95% CI
Anxiety Sensitivity Training40.17± 14.03
Health Control40.69± 13.15
2-Week Follow-up
GroupValue95% CI
Anxiety Sensitivity Training38.00± 15.13
Health Control37.24± 14.10
1-Month Follow-up
GroupValue95% CI
Anxiety Sensitivity Training37.74± 16.29
Health Control34.25± 13.93
Dutch Eating Behavior Questionnaire Primary · Baseline,1-week, 2-week and 1-month follow-up

The Dutch Eating Behavior Questionnaire will be used to assess emotional eating. Items are rated on a 5-point Likert scale ranging from 1 (never) to 5 (very often). For the current study, the emotional eating subscale (13 items) will be used as a measure of emotional eating. The 13 items of the subscale are summed and divided by 13 to create a mean score with a range from 1-5. Lower scores on this measure indicate better outcomes.

Baseline
GroupValue95% CI
Anxiety Sensitivity Training3.58± 0.91
Health Control3.68± 0.87
1-Week Follow-up
GroupValue95% CI
Anxiety Sensitivity Training3.54± 1.03
Health Control3.59± 0.92
2-Week Follow-up
GroupValue95% CI
Anxiety Sensitivity Training3.31± 1.08
Health Control3.52± 0.94
1-Month Follow-up
GroupValue95% CI
Anxiety Sensitivity Training3.21± 1.15
Health Control3.35± 0.98
Eating Expectancy Inventory Primary · Baseline,1-week, 2-week and 1-month follow-up

The Eating Expectancy Inventory will be used to measure cognitive expectancies of eating. The Eating Expectancy Inventory subscale facet: eating helps manage negative affect will be used in the current study. Respondents will be asked to rate on a 7-point Likert scale the degree to which they 1 (completely disagree) to 7 (completely agree) to each item. Responses are summed for each subscale. Lower scores on the 18-item eating helps manage negative affect subscale (possible range = 18 - 126) indicate better outcomes.

Baseline
GroupValue95% CI
Anxiety Sensitivity Training88.17± 22.11
Health Control90.06± 20.69
1-Week Follow-up
GroupValue95% CI
Anxiety Sensitivity Training85.98± 25.89
Health Control89.03± 23.08
2-Week Follow-up
GroupValue95% CI
Anxiety Sensitivity Training82.19± 26.18
Health Control88.30± 23.15
1-Month Follow-up
GroupValue95% CI
Anxiety Sensitivity Training80.74± 28.71
Health Control87.51± 22.59
Exercise Self-Efficacy Primary · Baseline,1-week, 2-week and 1-month follow-up

Exercise self-efficacy will be assessed with a 5-item self-report assessment of one's confidence about their ability to engage in physical activity. Items are rated on a 9-point Likert-type scale that ranges from 0 (not at all confident) to 8 (extremely confident). A total score will be created by summing the 5-items with higher scores indicating a better outcome (possible range 0 - 40).

Baseline
GroupValue95% CI
Anxiety Sensitivity Training14.11± 9.31
Health Control16.59± 8.13
1-Week Follow-up
GroupValue95% CI
Anxiety Sensitivity Training16.37± 9.77
Health Control18.06± 8.11
2-Week Follow-up
GroupValue95% CI
Anxiety Sensitivity Training15.52± 9.14
Health Control17.54± 8.48
1-Month Follow-up
GroupValue95% CI
Anxiety Sensitivity Training16.32± 9.51
Health Control17.20± 8.20

Sponsor's own description

The proposed study will design and evaluate a computerized-delivered single-session anxiety sensitivity reduction program (i.e., Anxiety Sensitivity Training; AST). The AST will be designed to achieve three primary aims: (1) provide psycho-educational information on AS and its consequences, (2) present psycho-educational information on the relationship between AS and obesity-related health behavior correlates, and (3) offer concrete, evidence-based strategies to facilitate motivation to change their obesity-related lifestyle behaviors.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Mechanisms of maladaptive eating behavior among individuals with obesity and pain: exploring rumination.
    Bevers LM, Rogers AH, Zvolensky MJ, Redmond BY. · · 2026 · PMID 42207434 · DOI 10.1007/s10865-026-00680-4

Verify or expand the search:

Other recruiting trials for Obesity

Currently open trials in the same condition.

Other University of Houston trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03917901.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing